Critical review of current clinical practice guidelines for antifungal therapy in paediatric haematology and oncology

Grants

Funding Acknowledgements

Prof Slavin has received investigator initiated funds from Merck and has previously been a member of advisory boards and speakers bureaus for Merck and Gilead Sciences. A/Prof Clark has previously received investigator-initiated research funds from Gilead. No funding was received in the preparation of this manuscript. Human ethics approval nor informed consent was required for this manuscript.